The mechanism of action of angiostatin: can you teach an old dog new tricks?

Thromb Haemost. 2002 Mar;87(3):394-401.

Abstract

What is angiostatin? In 1994, Folkman and colleagues published a landmark paper describing anti-tumor effects in mice with a purified fragment of plasminogen they named angiostatin (1). Although many papers have been published describing activities of cryptic polypeptides derived from plasminogen fragments, this was the first report which associated plasminogen kringles 1-4 as a suppressor of metastasis development. This review will describe what is known about the mechanism of action of angiostatin from the current literature.

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors / chemistry
  • Angiogenesis Inhibitors / pharmacology
  • Angiostatins
  • Animals
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Binding Sites
  • Humans
  • Mitochondrial Proton-Translocating ATPases / antagonists & inhibitors
  • Peptide Fragments / chemistry
  • Peptide Fragments / pharmacology
  • Peptide Fragments / physiology*
  • Plasminogen / chemistry
  • Plasminogen / pharmacology
  • Plasminogen / physiology*

Substances

  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • Peptide Fragments
  • Angiostatins
  • Plasminogen
  • Mitochondrial Proton-Translocating ATPases